Skip to main content
Premium Trial:

Request an Annual Quote

Canadian Bioinformatics Firm Raises $4.5 Million From Private Investors


MISSISSAUGA, Ont.--Last month Base4 Bioinformatics, a subsidiary here of Allelix Biopharmaceuti cals, announced that it has closed a private placement financing for $4.5 million. Investors include BioCapital Investments, Tera Capital, and Working Ventures Canadian Fund. The funding means that while Allelix remains a major shareholder in Base4, its share of the company has dropped to under 50 percent.

The new money will be used to extend Base4's library of bioinformatics software solutions, open more branch offices to improve customer service, and accelerate business development, according to Martin Sumner-Smith, Base4's president. Graham Stachan, Allelix's president and CEO, called the financing "a major step forward."

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.